High-Intensity Focused Ultrasound Ablation of Uterine Fibroids – Potential Impact on
                    Fertility and Pregnancy Outcome

M. K. Bohlmann; F. Hoellen; P. Hunold; M. David

doi:10.1055/s-0033-1360311

Geburtshilfe und Frauenheilkunde, Table of Contents

Geburtshilfe Frauenheilkd 2014; 74(2): 139-145
DOI: 10.1055/s-0033-1360311

Review

GebFra Science

Georg Thieme Verlag KG Stuttgart · New York

High-Intensity Focused Ultrasound Ablation of Uterine Fibroids – Potential Impact on Fertility and Pregnancy Outcome

Myombehandlung mittels hochintensiviertem fokussiertem Ultraschall – mögliche Auswirkung auf Fertilität und Schwangerschaftsausgang

M. K. Bohlmann

¹Department of Obstetrics and Gynaecology, University Hospital Schleswig-Holstein – Campus Lübeck, Lübeck

,

F. Hoellen

¹Department of Obstetrics and Gynaecology, University Hospital Schleswig-Holstein – Campus Lübeck, Lübeck

,

P. Hunold

²Clinic for Radiology and Nuclear Medicine, University Hospital Schleswig-Holstein – Campus Lübeck, Lübeck

,

M. David

³Klinik für Gynäkologie, Charité Campus Virchow-Klinikum, Berlin

› Author Affiliations

Abstract

Laparoscopic myomectomy is regarded as the gold standard for women with symptomatic fibroids who wish to become pregnant. High-intensity focused ultrasound (HIFU or MRgFUS) ablation of uterine fibroids is also being discussed as a non-surgical, minimally invasive, therapeutic option. This review examines the available data on the impact of HIFU/MRgFUS on fertility and pregnancy, focusing particularly on potential direct side-effects of this type of intervention on ovaries, fallopian tubes and uterus and potential late effects on pregnancy and birth, based on the current literature. All pregnancies after HIFU/MRgFUS published to date (around 100 cases) were evaluated. The published case series suggest that HIFU/MRgFUS ablation has no impact on the rate of miscarriages or other obstetrical outcome parameters. Because no prospective studies exist which permit firm conclusions to be drawn on the impact of HIFU/MRgFUS on fertility and pregnancy outcome in women with symptomatic fibroids, this approach is currently only recommended for women with suspected fertility problems due to uterine fibroids who either decline surgery or who have an unacceptably high surgical risk.

Zusammenfassung

Als Therapiestandard für Frauen mit Kinderwunsch und symptomatischen Myomen wird die möglichst wenig invasive operative Myomenukleation angesehen. Die Myombehandlung mit hochintensiviertem fokussiertem Ultraschall (HIFU/MRgFUS) wird als minimalinvasive Therapiemöglichkeit ebenfalls diskutiert. Diese Übersichtsarbeit wertet die vorhandene Literatur zum Thema „Einfluss von HIFU/MRgFUS auf Fertilität und Schwangerschaft“ aus, wobei sowohl mögliche direkte Nebenwirkungen der Intervention an sich auf Ovarien, Tuben und Uterus als auch mögliche spätere Auswirkungen auf Schwangerschaft und Geburt auf der Basis der vorliegenden Literatur ausführlich diskutiert werden. Die bisher publizierten knapp 100 Schwangerschaften nach HIFU/MRgFUS wurden ausgewertet. Die vorliegenden Fallserien legen nahe, dass eine HIFU/MRgFUS-Behandlung keinen Einfluss auf Abortrate sowie weitere geburtshilfliche Outcome-Parameter ausübt. Dennoch kann eine solche Therapie bis dato nur denjenigen Frauen mit vermuteten myomassoziierten Fertilitätsproblemen empfohlen werden, die chirurgische Maßnahmen ablehnen oder ein inakzeptabel hohes chirurgisches Risiko aufweisen, da keine prospektiven Studien vorliegen, die eine Aussage über den Einfluss der HIFU/MRgFUS-Therapie auf Fertilitätsrate und Schwangerschaftsausgang bei Frauen mit symptomatischen Myomen zulassen.

Key words

pregnancy - radiotherapy - sterility - ultrasound - uterus - uterine tumor

Schlüsselwörter

Schwangerschaft - Radiotherapie - Sterilität - Ultraschall - Uterus

Full Text

References

References
1 Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004; 104: 393-406
2 Jacoby VL, Fujimoto VY, Giudice LC et al. Racial and ethnic disparities in benign gynecologic conditions and associated surgeries. Am J Obstet Gynecol 2010; 202: 514-521
3 Hoellen F, Griesinger G, Bohlmann MK. Therapeutic drugs in the treatment of symptomatic uterine fibroids. Expert Opin Pharmacother 2013; 14: 2079-2085
4 Islam MS, Protic O, Giannubilo SR et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab 2013; 98: 921-934
5 Brady PC, Stanic AK, Styer AK. Uterine fibroids and subfertility: an update on the role of myomectomy. Curr Opin Obstet Gynecol 2013; 25: 255-259
6 Guven S, Kart C, Unsal MA et al. Intramural leoimyoma without endometrial cavity distortion may negatively affect the ICSI - ET outcome. Reprod Biol Endocrinol 2013; 11: 102
7 Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91: 1215-1223
8 Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2012; (11) CD003857
9 van der Kooij SM, Ankum WM, Hehenkamp WJ. Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol 2012; 24: 368-375
10 Guo XC, Segars JH. The impact and management of fibroids for fertility: an evidence-based approach. Obstet Gynecol Clin North Am 2012; 39: 521-533
11 David M, Kröncke T. Uterine fibroid embolisation – potential impact on fertility and pregnancy outcome. Geburtsh Frauenheilk 2013; 73: 247-255
12 Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 2010; 94: 324-330
13 Goldberg J, Pereira L. Pregnancy outcomes following treatment for fibroids: uterine fibroid embolization versus laparoscopic myomectomy. Curr Opin Obstet Gynecol 2006; 18: 402-406
14 Kröncke T, David M. Uterine artery embolization (UAE) for fibroid treatment: results of the 4th Radiological Gynecological Expert Meeting. RoFo 2013; 185: 461-463
15 Griffiths A, ter Haar G, Rivens I et al. High-intensity focused ultrasound in obstetrics and gynecology: the birth of a new era of noninvasive surgery?. Ultraschall in Med 2012; 33: E8-E15
16 Ruhnke H, Eckey T, Bohlmann MK et al. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice. Rofo 2013; 184: 983-991
17 Stewart EA, Gedroyc WM, Tempany CM et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003; 189: 48-54
18 Hindley J, Gedroyc WM, Regan L et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol 2004; 183: 1713-1719
19 Fennessy FM, Tempany CM. MRI-guided focused ultrasound surgery of uterine leiomyomas. Acad Radiol 2005; 12: 1158-1166
20 Stewart EA, Rabinovici J, Tempany CM et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006; 85: 22-29
21 Stewart EA, Gostout B, Rabinovici J et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol 2007; 110: 279-287
22 Rabinovici J, Inbar Y, Revel A et al. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol 2007; 30: 771-777
23 Bohlmann MK, Hunold P, Rabe T et al. Hochintensiver fokussierter Ultraschall. Neue diagnostische und therapeutische Optionen bei Patientinnen mit Myomen. J Reprod Endokrinol 2013; 10: 266-272
24 Rabinovici J, David M, Fukunishi H et al. MRgFUS Study Group. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril 2010; 93: 199-209
25 Beck A, David M, Kröncke T. Magnetresonanz-geführter fokussierter Ultraschall zur Myombehandlung – Ergebnisse des ersten radiologisch-gynäkologischen Expertentreffens. Fortschr Röntgenstr 2013; 185: 464-466
26 Rabinovici J, Inbar Y, Eylon SC et al. Pregnancy and live birth after focused ultrasound surgery for symptomatic focal adenomyosis: a case report. Hum Reprod 2006; 21: 1255-1259
27 Behera MA, Leong M, Johnson L et al. Eligibility and accessibility of magnetic resonance-guided focused ultrasound (MRgFUS) for the treatment of uterine leiomyomas. Fertil Steril 2010; 94: 1864-1868
28 Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol 2009; 34: 584-589
29 Okada A, Morita Y, Fukunishi H et al. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol 2009; 34: 579-583
30 Kim HS, Baik JH, Pham LD et al. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol 2011; 18: 970-976
31 Fukunishi H, Funaki K, Sawada K et al. Therapy of uterine myomas using MR-guided Focused Ultrasound Surgery (MRgFUS). A study of the non-enhanced areas around the myoma. Geburtsh Frauenheilk 2007; 67: 336-340
32 Ichimura T, Kawamura N, Ito F et al. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens. Fertil Steril 1998; 70: 967-971
33 Stovall DW. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound. Menopause 2011; 18: 437-444
34 Gorny KR, Woodrum DA, Brown DL et al. Magnetic resonance guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol 2011; 22: 857-864
35 Kamp JE, David M, Scheurig-Muenkler C et al. Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids. Rofo 2013; 185: 136-143
36 Machtinger R, Cohen-Eylon S, Admon D et al. MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success. Hum Reprod 2012; 27: 3425-3431
37 Wang SW, He XY, Li MZ. High-intensity focused ultrasound compared with irradiation for ovarian castration in premenopausal females with hormone receptor-positive breast cancer after radical mastectomy. Oncol Lett 2012; 4: 1087-1109
38 He GB, Luo W, Zhou XD et al. A preliminary clinical study on high-intensity focused ultrasound therapy for tubal pregnancy. Scott Med J 2011; 56: 214-219
39 Barnhart KT. Ectopic pregnancy. NEJM 2009; 361: 379-387
40 Yoshino O, Hayashi T, Osuga Y et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod 2010; 25: 2475-2479
41 Mara M, Fucikova Z, Kuzel D et al. Hysteroscopy after uterine fibroid embolization in women of fertile age. J Obstet Gynaecol Res 2007; 33: 316-324
42 Dong X, Yang Z. High-intensity focused ultrasound ablation of uterine localized adenomyosis. Curr Opin Obstet Gynecol 2010; 22: 326-330
43 Fruehauf JH, Back W, Eiermann A et al. High-intensity focused ultrasound for the targeted destruction of uterine tissues: experiences from a pilot study using a mobile HIFU unit. Arch Gynecol Obstet 2008; 277: 143-150
44 Hanstede MM, Tempany CM, Stewart EA. Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: a case report. Fertil Steril 2007; 88: 497.e5-497.e7
45 Millan Cantero H. 2011 Online: http://www.insightec.com/Pregnancy-research-ExAblate.html last access: 01.08.2013
46 Rabinovici J. 2012 Online: http://www.insightec.com/Pregnancy-research-ExAblate.html last access: 01.08.2013
47 Online: http://www.fibroidrelief.org/registry/ last access: 01.08.2013
48 Qin J, Chen JY, Zhao WP et al. Outcome of unintended pregnancy after ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroids. Int J Gynaecol Obstet 2012; 117: 273-277
49 Memtsa M, Homer H. Complications associated with uterine artery embolization for fibroid. Obstet Gynecol Int 2012; 2012: 290542
50 Online: http://www.deutsches-ivf-register.de/pdf-downloads/dirjahrbuch2011-d.pdf last access: 01.08.2013
51 Tropeano G, Amoroso S, Scambia G. Non-surgical management of uterine fibroids. Hum Reprod Update 2008; 14: 259-274
52 Gedroyc WM. MRgFUS: a sound approach to fibroid therapy. Ultrasound Obstet Gynecol 2009; 34: 494-496
53 David M, Kröncke T. Preoperative uterine artery embolisation for large uterine fibroids with subsequent uterus preservation – three case histories and review of the literature. Geburtsh Frauenheilk 2012; 72: 539-542
54 BQS-Bundesgeschäftsstelle Qualitätssicherung gGmbH. Landesauswertung Qualitätssicherung Berlin, Berliner Klinikgeburten 2011. BQS-Hamburg 2012.
55 Gavrilova-Jordan LP, Rose CH, Traynor KD et al. Successful term pregnancy following MR-guided focused ultrasound treatment of uterine leiomyoma. J Perinatol 2007; 27: 59-61
56 Morita Y, Ito N, Ohashi H. Pregnancy following MR-guided focused ultrasound surgery for a uterine fibroid. Int J Gynaecol Obstet 2007; 99: 56-57
57 Zaher S, Lyons D, Regan L. Uncomplicated term vaginal delivery following magnetic resonance-guided focused ultrasound surgery for uterine fibroids. Biomed Imaging Interv J 2010; 6: e28
58 Yoon SW, Kim KA, Kim SH et al. Pregnancy and natural delivery following magnetic resonance imaging-guided focused ultrasound surgery of uterine myomas. Yonsei Med J 2010; 51: 451-453
59 Bouwsma EV, Gorny KR, Hesley GK et al. Magnetic resonance-guided focused ultrasound surgery for leiomyoma-associated infertility. Fertil Steril 2011; 96: e9-e12
60 Millan Cantero H, Suárez Ramos J, García Laffitte E et al. First three cases in Spain of term pregnancy after treatment of uterine fibroid with non-invasive MRgFUS surgery. Prog Obstet Ginecol 2011; 54: 601-604
61 Zaher S, Lyons D, Regan L. Successful in vitro fertilization pregnancy following magnetic resonance-guided focused ultrasound surgery for uterine fibroids. J Obstet Gynaecol Res 2011; 37: 370-373

Supplementary Material

German supporting informations for this article